Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Thrombosis and Haemostasis|April 12, 1990
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosisF Violi, D Ferro, C Quintarelli, et al.BMJ (Clinical Research Ed.)|April 28, 1990
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosisF Violi, D Ferro, G Valesini, et al.Hepatology (Baltimore, Md.)|June 1, 1996
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemiaD Ferro, C Quintarelli, A Lattuada, et al.Clinical and Experimental Rheumatology|November 1, 1989
Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodiesG Valesini, F Violi, D Ferro, et al.Hepatology (Baltimore, Md.)|April 1, 1992
Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosisF Violi, D Ferro, S Basili, et al.Circulation|March 18, 1997
Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic stateD Ferro, V Pittoni, C Quintarelli, et al.Scandinavian Journal of Gastroenterology|October 1, 1992
1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression modelD Ferro, M Saliola, C Quintarelli, et al.British Journal of Pharmacology|December 1, 1996
Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamoleL Iuliano, A R Colavita, C Camastra, et al.Journal of Clinical Pathology|April 1, 1992
Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosusD Ferro, M Saliola, C Quintarelli, et al.Leukemia|April 30, 2010
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyV Hoyos, B Savoldo, C Quintarelli, et al.Pageof 3